HERBALIFE LTD (HLF) Fundamental Analysis & Valuation

NYSE:HLF • KYG4412G1010

Current stock price

13.89 USD
-0.5 (-3.47%)
At close:
13.89 USD
0 (0%)
After Hours:

This HLF fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. HLF Profitability Analysis

1.1 Basic Checks

  • HLF had positive earnings in the past year.
  • HLF had a positive operating cash flow in the past year.
  • HLF had positive earnings in each of the past 5 years.
  • Each year in the past 5 years HLF had a positive operating cash flow.
HLF Yearly Net Income VS EBIT VS OCF VS FCFHLF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.19%, HLF is in the better half of the industry, outperforming 72.97% of the companies in the same industry.
Industry RankSector Rank
ROA 8.19%
ROE N/A
ROIC N/A
ROA(3y)7.53%
ROA(5y)10.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HLF Yearly ROA, ROE, ROICHLF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100

1.3 Margins

  • HLF's Profit Margin of 4.53% is fine compared to the rest of the industry. HLF outperforms 67.57% of its industry peers.
  • In the last couple of years the Profit Margin of HLF has declined.
  • HLF's Operating Margin has declined in the last couple of years.
  • The Gross Margin of HLF (77.87%) is better than 86.49% of its industry peers.
  • In the last couple of years the Gross Margin of HLF has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 4.53%
GM 77.87%
OM growth 3Y-3.15%
OM growth 5Y-3.06%
PM growth 3Y-9.79%
PM growth 5Y-7.59%
GM growth 3Y0.18%
GM growth 5Y-0.35%
HLF Yearly Profit, Operating, Gross MarginsHLF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

2

2. HLF Health Analysis

2.1 Basic Checks

  • HLF does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, HLF has more shares outstanding
  • Compared to 5 years ago, HLF has less shares outstanding
  • The debt/assets ratio for HLF has been reduced compared to a year ago.
HLF Yearly Shares OutstandingHLF Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
HLF Yearly Total Debt VS Total AssetsHLF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 1.12, we must say that HLF is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of HLF (1.12) is comparable to the rest of the industry.
  • The Debt to FCF ratio of HLF is 7.88, which is on the high side as it means it would take HLF, 7.88 years of fcf income to pay off all of its debts.
  • HLF has a Debt to FCF ratio (7.88) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.88
Altman-Z 1.12
ROIC/WACCN/A
WACC10.03%
HLF Yearly LT Debt VS Equity VS FCFHLF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

2.3 Liquidity

  • HLF has a Current Ratio of 1.13. This is a normal value and indicates that HLF is financially healthy and should not expect problems in meeting its short term obligations.
  • HLF's Current ratio of 1.13 is on the low side compared to the rest of the industry. HLF is outperformed by 72.97% of its industry peers.
  • A Quick Ratio of 0.62 indicates that HLF may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.62, HLF is not doing good in the industry: 72.97% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.62
HLF Yearly Current Assets VS Current LiabilitesHLF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. HLF Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 8.67% over the past year.
  • The earnings per share for HLF have been decreasing by -10.16% on average. This is quite bad
  • Looking at the last year, HLF shows a small growth in Revenue. The Revenue has grown by 0.89% in the last year.
  • The Revenue has been decreasing by -1.89% on average over the past years.
EPS 1Y (TTM)8.67%
EPS 3Y-14.35%
EPS 5Y-10.16%
EPS Q2Q%25%
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-1.08%
Revenue growth 5Y-1.89%
Sales Q2Q%6.26%

3.2 Future

  • HLF is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.82% yearly.
  • Based on estimates for the next years, HLF will show a small growth in Revenue. The Revenue will grow by 4.29% on average per year.
EPS Next Y20.74%
EPS Next 2Y17.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.67%
Revenue Next 2Y4.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HLF Yearly Revenue VS EstimatesHLF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
HLF Yearly EPS VS EstimatesHLF Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

8

4. HLF Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 6.52, the valuation of HLF can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of HLF indicates a rather cheap valuation: HLF is cheaper than 91.89% of the companies listed in the same industry.
  • HLF's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.60.
  • A Price/Forward Earnings ratio of 5.40 indicates a rather cheap valuation of HLF.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HLF indicates a rather cheap valuation: HLF is cheaper than 94.59% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.84. HLF is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.52
Fwd PE 5.4
HLF Price Earnings VS Forward Price EarningsHLF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, HLF is valued cheaper than 91.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.68
EV/EBITDA N/A
HLF Per share dataHLF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HLF's earnings are expected to grow with 17.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y17.82%
EPS Next 3YN/A

0

5. HLF Dividend Analysis

5.1 Amount

  • No dividends for HLF!.
Industry RankSector Rank
Dividend Yield 0%

HLF Fundamentals: All Metrics, Ratios and Statistics

HERBALIFE LTD

NYSE:HLF (4/2/2026, 7:00:00 PM)

After market: 13.89 0 (0%)

13.89

-0.5 (-3.47%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-18
Earnings (Next)04-28
Inst Owners102.08%
Inst Owner Change3.28%
Ins Owners1.99%
Ins Owner Change0.81%
Market Cap1.44B
Revenue(TTM)5.04B
Net Income(TTM)228.30M
Analysts77.78
Price Target17.34 (24.84%)
Short Float %8.47%
Short Ratio5.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.93%
Min EPS beat(2)4.47%
Max EPS beat(2)7.39%
EPS beat(4)4
Avg EPS beat(4)30.94%
Min EPS beat(4)4.47%
Max EPS beat(4)59.17%
EPS beat(8)8
Avg EPS beat(8)40.78%
EPS beat(12)9
Avg EPS beat(12)22.69%
EPS beat(16)13
Avg EPS beat(16)25.36%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)2.07%
Revenue beat(4)1
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)2.07%
Revenue beat(8)2
Avg Revenue beat(8)-0.99%
Revenue beat(12)6
Avg Revenue beat(12)-0.06%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)0%
PT rev (3m)41.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.78%
EPS NY rev (1m)-2.76%
EPS NY rev (3m)-2.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.1%
Revenue NY rev (1m)1.65%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE 6.52
Fwd PE 5.4
P/S 0.29
P/FCF 5.68
P/OCF 4.31
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)2.13
EY15.33%
EPS(NY)2.57
Fwd EY18.52%
FCF(TTM)2.45
FCFY17.61%
OCF(TTM)3.22
OCFY23.21%
SpS48.73
BVpS-4.98
TBVpS-9
PEG (NY)0.31
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 8.19%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4.53%
GM 77.87%
FCFM 5.02%
ROA(3y)7.53%
ROA(5y)10.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)29.25%
ROCE(5y)32.45%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.15%
OM growth 5Y-3.06%
PM growth 3Y-9.79%
PM growth 5Y-7.59%
GM growth 3Y0.18%
GM growth 5Y-0.35%
F-Score6
Asset Turnover1.81
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.88
Debt/EBITDA N/A
Cap/Depr 66.34%
Cap/Sales 1.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 110.78%
Current Ratio 1.13
Quick Ratio 0.62
Altman-Z 1.12
F-Score6
WACC10.03%
ROIC/WACCN/A
Cap/Depr(3y)95.33%
Cap/Depr(5y)112.44%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.46%
Profit Quality(3y)110.5%
Profit Quality(5y)92.32%
High Growth Momentum
Growth
EPS 1Y (TTM)8.67%
EPS 3Y-14.35%
EPS 5Y-10.16%
EPS Q2Q%25%
EPS Next Y20.74%
EPS Next 2Y17.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-1.08%
Revenue growth 5Y-1.89%
Sales Q2Q%6.26%
Revenue Next Year4.67%
Revenue Next 2Y4.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-231.85%
EBIT growth 3Y-4.2%
EBIT growth 5Y-4.89%
EBIT Next Year36.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.77%
FCF growth 3Y8.85%
FCF growth 5Y-13.31%
OCF growth 1Y16.78%
OCF growth 3Y-1.85%
OCF growth 5Y-11.92%

HERBALIFE LTD / HLF Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HERBALIFE LTD?

ChartMill assigns a fundamental rating of 4 / 10 to HLF.


What is the valuation status for HLF stock?

ChartMill assigns a valuation rating of 8 / 10 to HERBALIFE LTD (HLF). This can be considered as Undervalued.


Can you provide the profitability details for HERBALIFE LTD?

HERBALIFE LTD (HLF) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for HLF stock?

The Price/Earnings (PE) ratio for HERBALIFE LTD (HLF) is 6.52 and the Price/Book (PB) ratio is -2.79.


How financially healthy is HERBALIFE LTD?

The financial health rating of HERBALIFE LTD (HLF) is 2 / 10.